- Featured Product
- KD/KO Validated
ACLY Polyclonal Antibody for FC, IF, IP, WB, ELISA
Cat no : 15421-1-AP
ACL, ACLY, ATP citrate (pro S ) lyase, ATP citrate lyase, ATP citrate synthase, ATPCL, Citrate cleavage enzyme, CLATP
|Positive WB detected in||L02 cells, HeLa cells, K-562 cells, Jurkat cells, mouse liver tissue, rat liver tissue|
|Positive IP detected in||K-562 cells|
|Positive IF detected in||HepG2 cells|
|Positive FC detected in||HepG2 cells|
|Western Blot (WB)||WB : 1:1000-1:4000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:500-1:2000 for WB|
|Immunofluorescence (IF)||IF : 1:10-1:100|
|Sample-dependent, check data in validation data gallery|
15421-1-AP targets ACLY in WB, IP, IHC, IF, FC, ELISA applications and shows reactivity with human, mouse, rat samples.
|Reactivity||human, mouse, rat|
|Cited Species||human, mouse|
|Host / Isotype||Rabbit / IgG|
|Immunogen||ACLY fusion protein Ag7709|
|Full Name||ATP citrate lyase|
|Calculated molecular weight||121 kDa|
|Observed molecular weight||120 kDa|
|GenBank accession number||BC006195|
|Gene ID (NCBI)||47|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
ACLY(ATP-citrate synthase) is also named as ACL. It is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA. ACLY serves as not only a target in oxygenated cells for suppression of lipid synthesis and histone acetylation, but also as a susceptible target in hypoxic cells to restore inhibition of glycolysis. In nonsmall cell lung carcinoma and hepatocellular carcinoma, ACLY is overexpressed compared with normal parenchyma suggesting that ACLY may represent a common target among highly malignant tumors(PMID:19795461). This protein has 2 isoforms produced by alternative splicing.
|Product Specific Protocols|
|WB protocol for ACLY antibody 15421-1-AP||Download protocol|
|IF protocol for ACLY antibody 15421-1-AP||Download protocol|
|IP protocol for ACLY antibody 15421-1-AP||Download protocol|
|FC protocol for ACLY antibody 15421-1-AP||Download protocol|
|Click here to view our Standard Protocols|
Polarization of Human Macrophages by Interleukin-4 Does Not Require ATP-Citrate Lyase.
Adipocyte ACLY Facilitates Dietary Carbohydrate Handling to Maintain Metabolic Homeostasis in Females.
J Exp Clin Cancer Res
ACLY facilitates colon cancer cell metastasis by CTNNB1.
Int J Mol Sci
Knockdown of PKM2 Suppresses Tumor Growth and Invasion in Lung Adenocarcinoma.
Emodin Induced SREBP1-Dependent and SREBP1-Independent Apoptosis in Hepatocellular Carcinoma Cells.
Int J Biol Sci
DJ-1 Deficiency Protects Hepatic Steatosis by Enhancing Fatty Acid Oxidation in Mice.